Screener
CG Oncology CGON Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from CG Oncology’s reported figures.
Based on trailing twelve months.
The source filing: CG Oncology’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336918
FAQ
- What is CG Oncology's operating margin?
- CG Oncology (CGON) reported operating margin of -4,056.2% in Q2 2026.
- How has CG Oncology's operating margin changed year-over-year?
- CG Oncology's operating margin increased by 85.8% year-over-year, from -28,546.1% to -4,056.2%.
- What is the long-term trend for CG Oncology's operating margin?
- Over 2 years (2023 to 2025), CG Oncology's operating margin has grown at a -58.3% compound annual growth rate (CAGR), from -27,178.9% to -4,722.1%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about CG Oncology's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude